Laura Sepp-Lorenzino
Directeur Technique/Scientifique/R&D chez INTELLIA THERAPEUTICS, INC.
Fortune : 582 784 $ au 31/05/2024
Profil
Laura Sepp-Lorenzino est directrice indépendante de Taysha Gene Therapies, Inc. et Chief Scientific Officer & Executive VP d'Intellia Therapeutics, Inc. Elle est membre du conseil d'administration de Taysha Gene Therapies, Inc. Le Dr Sepp-Lorenzino a été précédemment employée en tant que vice-présidente, responsable des thérapies par acide nucléique et de la recherche chez Vertex Pharmaceuticals, Inc, vice-présidente chez Alnylam Pharmaceuticals, Inc, et directrice exécutive et responsable des thérapies par ARN chez Merck & Co, Inc. Elle a obtenu son diplôme de premier cycle à l'Université de Buenos Aires, un diplôme d'études supérieures à l'Université de New York et un doctorat à l'Université de New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 19 362 ( 0,02% ) | 413 960 $ | 31/05/2024 | |
| 29/05/2024 | 49 220 ( 0,03% ) | 168 825 $ | 31/05/2024 |
Postes actifs de Laura Sepp-Lorenzino
| Sociétés | Poste | Début |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/05/2019 |
| TAYSHA GENE THERAPIES, INC. | Directeur/Membre du Conseil | 23/11/2020 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Directeur/Membre du Conseil | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Directeur/Membre du Conseil | - |
Anciens postes connus de Laura Sepp-Lorenzino
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/05/2019 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2017 |
| MERCK & CO., INC. | Directeur/Membre du Conseil | 01/03/2014 |
Formation de Laura Sepp-Lorenzino
| New York University | Doctorate Degree |
| Universidad de Buenos Aires | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
